SCHEMBL18409205

SCHEMBL18409205

CCc1cc(C#N)ccc1Nc1cc2c(ncn2C)c(NC(C)=O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 6/20 0.40
▸ JAK1 P23458 6/20 0.40
▸ TYK2 P29597 6/20 0.40
▸ JAK3 P52333 6/20 0.40
▸ ABCC9 O60706 1/20 0.36
▸ ABCC8 Q09428 1/20 0.36
▸ KCNJ11 Q14654 1/20 0.36
▸ KCNJ8 Q15842 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ SETDB1 Q15047 1/20 0.35
▸ TNIK Q9UKE5 1/20 0.34
▸ EGLN2 Q96KS0 1/20 0.33
▸ MOK Q9UQ07 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PRKDC P78527 1/20 0.33
▸ STK4 Q13043 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398581 0.88 JAK2 (0.53) JAK2JAK1TYK2JAK3DYRK1A
SCHEMBL18409286 0.83 JAK2 (0.47) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL18409204 0.81 JAK2 (0.45) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL18398321 0.80 IKBKB (0.37) JAK1TYK2ALDH1A1MAPTTNIK
SCHEMBL18409176 0.80 TYK2 (0.48) JAK2JAK1TYK2JAK3DYRK1A
SCHEMBL18409133 0.79 TYK2 (0.42) JAK2JAK1TYK2JAK3CTSS
SCHEMBL18398390 0.79 ITK (0.39) ALDH1A1MAPTDYRK1AADORA2A
SCHEMBL18398461 0.78 JAK2 (0.36) JAK2JAK1TYK2JAK3ABCC9
SCHEMBL15174569 0.76 PRKDC (0.43) JAK2JAK1TYK2JAK3ABCC9
SCHEMBL18409106 0.74 KMT2A (0.35) JAK2JAK1TYK2JAK3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback